Circulatory Support for High-Risk Coronary Artery Bypass Grafting and Coronary Interventions: Where is the Evidence?

Andrew J Gorton1, Suresh Keshavamurthy1

  • 1Division of Cardiothoracic Surgery, Department of Surgery, University of Kentucky, Lexington, Kentucky.

Insights

Mechanical circulatory support (MCS) devices help reduce risks for high-risk patients undergoing coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI). This review examines evidence, patient groups, and outcomes for temporary MCS use.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Medical Devices

Background:

  • Coronary artery disease is a leading global cause of death.
  • High-risk patients undergoing coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) face significant perioperative challenges.
  • Mechanical circulatory support (MCS) devices are increasingly used to manage these risks.

Purpose of the Study:

  • To review the evidence for temporary MCS in high-risk CABG and PCI.
  • To define high-risk patient populations for these procedures.
  • To compare the benefits, risks, and outcomes of different temporary MCS devices.

Main Methods:

  • Literature review of studies on temporary mechanical circulatory support.
  • Analysis of patient data to define high-risk criteria.
  • Comparative assessment of device-specific performance and outcomes.

Main Results:

  • Evidence supports the use of temporary MCS in select high-risk patients undergoing CABG and PCI.
  • Specific patient characteristics identify high-risk individuals.
  • Different MCS devices offer varying benefits and risks, impacting clinical outcomes.

Conclusions:

  • Temporary MCS can mitigate perioperative risks in high-risk cardiac interventions.
  • Careful patient selection and device choice are crucial for optimal outcomes.
  • Further research is needed to refine indications and compare long-term effectiveness.